Señales en vivo de PCIB.OL | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 09:03):

Stats
Volumen de hoy	157 385
Volumen promedio	76 640.00
Capitalización de mercado	56.14M
EPS	NOK0 ( 2024-02-14 )
Próxima fecha de ganancias	( NOK0 ) 2024-05-09
Last Dividend	NOK0 ( N/A )
Next Dividend	NOK0 ( N/A )
P/E	-1.900
ATR14	NOK0.0250 (1.66%)

PCI Biotech Holding ASA Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PCI Biotech Holding ASA Finanzas

Annual	2023
Ingresos:	NOK0
Beneficio Bruto:	NOK-371 000 (0.00 %)
EPS:	NOK-0.540

FY	2023
Ingresos:	NOK0
Beneficio Bruto:	NOK-371 000 (0.00 %)
EPS:	NOK-0.540

FY	2022
Ingresos:	NOK0
Beneficio Bruto:	NOK-633 000 (0.00 %)
EPS:	NOK-1.440

FY	2021
Ingresos:	NOK0.00
Beneficio Bruto:	NOK0.00 (0.00 %)
EPS:	NOK-0.843

Financial Reports:

No articles found.

PCI Biotech Holding ASA

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.